FOCUS-PDCA循环法在输血反应上报中的应用  

Improving the Reporting of Adverse Reactions with FOCUS-PDCA Cycle in Clinical Blood Transfusion

作　　者：王巍东[1] 王晶晶[2] 李闯[1] 申家辉[1] 李志强[3] WANG Wei-dong;WANG Jing-jing;LI-Chuang(Department of Transfusion,Third Affiliated Hospital of Xinxiang Medical College,Henan 453003)

机构地区：[1]新乡医学院第三附属医院输血科,453003 [2]新乡医学院第一附属医院肿瘤科 [3]上海交通大学附属第六人民医院输血科

出　　处：《临床输血与检验》2022年第1期88-92,共5页Journal of Clinical Transfusion and Laboratory Medicine

摘　　要：目的探讨FOCUS-PDCA循环法在提高输血不良反应上报中的作用。方法2015~2018年的输血病例作为对照组,应用FOCUS-PDCA循环法,对2019年本院输血不良反应上报过程进行持续改进。结果通过新的输血不良反应上报制度的建立,设定目标值为100%,使用FOCUS-PDCA循环法,输血不良反应的上报执行率逐步上升至98%。且输血不良反应发生率增至为0.74%,分别与历年相比有统计学差异(χ^(2)=81.64,P<0.05)。结论应用FOCUS-PDCA循环法明显提高了输血不良反应上报执行率,在临床输血质量管理方面起到了重要作用,值得临床推广。Objective To explore a FOCUS-PDCA cycle approach to improve reporting of adverse reactions to blood transfusion.Methods The FOCUS-PDCA cycle approach was applied to continuously improve the reporting process of adverse reactions associated with transfusion in 2019 versus transfusion cases from 2015 to 2018 in the control group.Results Through the establishment of a novel system for reporting adverse transfusion reactions,the target value was set at 100%.The implementation rate of adverse reactions gradually increased to 98%by FOCUS-PDCA cycle approach.The incidence of adverse reactions increased to 0.74%,with statistically significant differences compared to the previous year(χ^(2)=81.64,P<0.05).Conclusion The application of the FOCUS-PDCA cycle approach significantly improved the execution rate of adverse transfusion reactions reported.It plays an important role in clinical blood transfusion quality management and is worthy of promotion.

关 键 词：FOCUS-PDCA循环法 输血反应 上报执行率 

分 类 号：R457.13[医药卫生—治疗学]